Merck & Co. Inc. buy BMO Capital Markets
Start price
27.10.23
/
50%
€101.00
Target price
27.10.24
€125.02
Performance (%)
19.41%
Price
12:09
€119.20
Summary
This prediction is currently active. The BUY prediction by BMO_Capital_Markets currently has a performance of 19.41%. Dividends of €1.41 are taken into consideration when calculating the performance. This prediction currently runs until 27.10.24. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Merck & Co. Inc. | 0.501% | 0.501% |
iShares Core DAX® | -1.816% | -2.419% |
iShares Nasdaq 100 | 4.333% | 8.073% |
iShares Nikkei 225® | 0.657% | 1.234% |
iShares S&P 500 | 2.968% | 4.613% |
Comments by BMO_Capital_Markets for this prediction
In the thread Merck & Co. Inc. diskutieren
Merck & Co., Inc. (NYSE: MRK) was upgraded by analysts at BMO Capital Markets from a "market perform" rating to an "outperform" rating. They now have a $132.00 price target on the stock.
Ratings data for MRK provided by MarketBeat